RespireRx Pharmaceuticals Inc (fka RSPI)

[LTListener]

Agree.

With the capital levels they are seeking AND activities of having multiple candidates heading into human clinical trials AND multiple grant fundings, this will be controlled by sophisticated and institutional investors moving forward. I suspect in the near future there will be some significant bids while on the EM and this will gradually rise as both the exit from the EM becomes clearer as well as the status heading into clinical trials.

I would think with a significant capital raise they can eliminate remaining debt and conversions, maybe even buyout some warrants that all will tighten supply prior to exiting the EM. I don't believe this will be at .50 as some are hoping, but would not surprise me one bit to see this at .05 or more upon exit. Now if any elephant in the room shows itself prior to exiting EM, all bets are off as to how high this can go...

IMO and GLTA.